Shopping Cart
- Remove All
Your shopping cart is currently empty
Poloxamer 188 is a nonionic triblock copolymer surfactant and bioactive excipient used as a medical excipient to exacerbate cerebral amyloidosis, presynaptic dystrophy, and pathogenic microglial cell activation in 5XFAD mice.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 50 mg | Inquiry | Backorder | |
| 100 mg | Inquiry | Backorder |
| Description | Poloxamer 188 is a nonionic triblock copolymer surfactant and bioactive excipient used as a medical excipient to exacerbate cerebral amyloidosis, presynaptic dystrophy, and pathogenic microglial cell activation in 5XFAD mice. |
| In vitro | Poloxamer 188 exhibited a protective effect on mouse brain microvascular endothelial cells (MBEC) after treatment in the concentration range of 10-1000 μM for 5 hours. In addition, Docetaxel-loaded PLGA/Poloxamer 188 nanoparticles significantly increased drug uptake levels and cytotoxicity in Docetaxel-resistant MCF-7 TAX30 human breast cancer cells compared to Docetaxel-loaded PLGA nanoparticles. [1][2] |
| In vivo | Poloxamer 188 administered intravenously at a dose of 150 mg/kg over 240 minutes significantly reduced muscle edema and lipid peroxidation induced by ischemia-reperfusion. [3] |
| Cas No. | 691397-13-4 |
| Storage | store at low temperature,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.